Drew McCartney, Operating Committee Member of BelHealth, Joins Skila as Chief Executive Officer
Summary
Mr. McCartney developed and executed the global strategic marketing direction for Baxters $250 million blood systems unit, through which the company achieved significant sales growth, new product introductions and licensing relationships with partners worldwide.Prior to that, Drew was CEO of First Circle Medical and raised substantial capital from a combination of Boston Scientific Corporation, Tyco International and private equity and established commercial operations in Europe and China.Having run an array of health care technology growth platforms, I’ll bring a sense of the client’s perspective that will be additive to the successes that Skila has achieved working with the world’s leading pharmaceutical companies.Prior to that, Drew was CEO of First Circle Medical and raised substantial capital from a combination of Boston Scientific Corporation, Tyco International and private equity and established commercial operations in Europe and China.Having run an array of health care technology growth platforms, I’ll bring a sense of the client’s perspective that will be additive to the successes that Skila has achieved working with the world’s leading pharmaceutical companies.